I

Initiator Pharma A/S
STO:INIT

Watchlist Manager
Initiator Pharma A/S
STO:INIT
Watchlist
Price: 7.1 SEK 2.9% Market Closed
Market Cap: 375.7m SEK
Have any thoughts about
Initiator Pharma A/S?
Write Note

Initiator Pharma A/S
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Initiator Pharma A/S
Accounts Payable Peer Comparison

Comparables:
GMAB
ZEAL
ASND
B
BAVA
BIOPOR

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
I
Initiator Pharma A/S
STO:INIT
Accounts Payable
kr407k
CAGR 3-Years
-15%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Accounts Payable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zealand Pharma A/S
CSE:ZEAL
Accounts Payable
kr229.7m
CAGR 3-Years
61%
CAGR 5-Years
50%
CAGR 10-Years
38%
Ascendis Pharma A/S
NASDAQ:ASND
Accounts Payable
€99.5m
CAGR 3-Years
31%
CAGR 5-Years
36%
CAGR 10-Years
40%
B
Bavarian Nordic A/S
CSE:BAVA
Accounts Payable
kr1.1B
CAGR 3-Years
56%
CAGR 5-Years
59%
CAGR 10-Years
29%
Bioporto A/S
CSE:BIOPOR
Accounts Payable
kr5.5m
CAGR 3-Years
16%
CAGR 5-Years
18%
CAGR 10-Years
13%

See Also

What is Initiator Pharma A/S's Accounts Payable?
Accounts Payable
407k DKK

Based on the financial report for Dec 31, 2023, Initiator Pharma A/S's Accounts Payable amounts to 407k DKK.

What is Initiator Pharma A/S's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
11%

Over the last year, the Accounts Payable growth was -49%. The average annual Accounts Payable growth rates for Initiator Pharma A/S have been -15% over the past three years , 11% over the past five years .

Back to Top